INTRODUCTION
Hepatic dysfunction has been associated with poor prognosis in critically ill patients. Such patients are among the most carefully monitored patients in the hospital, controlled with many daily repeated tests. Interpretation of some of these tests included in the daily biochemical assessment can be challenging. 1 Bilirubin and liver enzymes that constitute routine liver function test (LFT) panel demonstrate results in the abnormal range which may fluctuate during the admission period. It has been reported that early detection of some abnormalities, 141 such as liver dysfunctions and their treatment can reduce mortality rates and improve health outcomes. 2 Liver failure is a situation in which rapid deterioration of liver function results in altered mentation and coagulopathy in previously normal people. In such patients, disturbance in LFTs or overt hepatic dysfunction are apparent. Multiple mechanisms such as metabolic, hemodynamic, and inflammatory factors underline the pathophysiological pathways of liver damage. 2, 3 Laboratory measurement of liver function is available in most intensive care units (ICUs); therefore, determination of its clinical significance has both therapeutic and prognostic values. Indications such as disease severity and prognosis of patients must be used for selecting the patients requiring ICU care. Determining the prognosis of the patients is also useful for choosing the most effective treatments, which can lead to better clinical results. 1, 3 Based on the different markers that have been used as indicators of hepatic dysfunction, the prevalence of liver failure was reported to vary from 6% to 61% on the first day of admission in adult ICUs. 2 Since bilirubin has been used as a key indicator of liver dysfunction in ICU critical illness scoring systems including Simplified "Sequential Organ Failure Assessment (SOFA)" score and "Simplified Acute Physiology Score (SAPS)", it has been the main focus of literature with regard to the liver failure. 4 Previous studies have revealed that elevated serum bilirubin > 2 mg/dL was linked to the severity of illness and had a negative effect on both mortality and length of stay. 4, 5 As clinical jaundice develops only several days after hepatic injury ensues, liver dysfunction has been considered as a late event in sepsis and multi-organ failure. 1 Moreover, it was seen that abnormal aspartate aminotransferase (AST), alkaline phosphatase (AKP), and gamma glutamyl transferase were correlated with increased risk of mortality within 30 days of admission in ICU. 2 Therefore, early liver dysfunction is a subtle but prevalent phenomenon in adult critical illnesses and is associated with poor outcomes. However, there is a paucity of data evaluating LFTs on admission and through the subsequent days as a predictor of outcomes in critically ill children. In the present study we aimed to describe and clarify the prevalence, patterns, and significance of abnormal LFTs as a predictive marker of mortality and hospital length of admission of ill children in the absence of pre-existing liver diseases.
MATERIALS AND METHODS

Ethics consideration
All experimental procedures were approved by the Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran and the study was in accordance with the Helsinki declaration of 1975, as revised in 2008. Informed consent was obtained from the parents or guardians of the participants.
Study subjects and setting
This study was conducted prospectively in a 10-bed medical pediatric intensive care unit (PICU) at Nemazee Hospital affiliated to Shiraz University of Medical Sciences, Shiraz, Iran, between April and October 2013. The study group included 149 patients aged from 1 month to 18 years admitted to PICU. Patients with chronic liver diseases and hepatitis with viral, pharmacological, or toxic origin were excluded from the study. Children who died in the first 6 hours after admission and patients with readmission episodes were also excluded.
Variables measurement
The values of liver function tests including ALT, AST, AKP, total bilirubin (TBILI), direct bilirubin (DBILI), and international normalized ratio (INR) were recorded on the first day of admission as a part of a biochemical 'PICU profile'. All the tests were also repeated 48 and 96 hours after admission. In order to standardize the analysis, only the results of the tests taken in the morning rounds were recorded for the study. Information regarding demographic data, primary PICU diagnosis, PICU length of stay (LOS), Pediatric Risk of Mortality Score (PRISM-III) score, and outcomes were documented as well.
Liver enzymes level were considered abnormal if they were ≥ ¼ time of upper normal limit. ALT, TBILI, DBILI, and INR were also considered abnormal if they were higher than the upper limit of the laboratory levels. Because all the measurements were performed as a part of the routine metabolic evaluation of the patients and the confidentiality procedures were maintained, the requirement for informed consent was waived for the admission PICU profile, but written informed consents were obtained from the parents or guardians in case of repeated tests needed 48 and 96 hours after admission.
Statistical analysis
Data analyses were accomplished using SPSS software, version 19 (SPSS Inc., Chicago, IL, USA). Normal distribution of data was examined using KolmogorovSmirnov test. All quantitative variables were presented as mean ± standard deviation of mean (SD) and qualitative variables were presented as frequency and percent. Independent student t test was used for comparison of quantitative variables. Paired t test, Chi-square, Fisher's exact test, and Mann-Whitney test were used as appropriate. To control confounders and find the variables related to dependent variables that fit the final predictive model, univariable and multivariable logistic regression analyses were performed. In all analyses, p < 0.05 was considered as statistically significant.
RESULTS
A total of 149 patients admitted to PICU were enrolled in this study. Among the participants, 76 (51%) were male and 73 (49%) were female and the patients' average age was 2 years (IQR: 0.58-8.4 years). Mean PRISM III score was 6 (range 3 to 39) and overall mortality rate was 24.2% (36 out of 149). The most frequent causes of admissions were infectious diseases (22.1%).
Frequencies of neurological, respiratory, cardiac, and endocrine disorders were 19.4%, 15%, 11.4%, and 10.7%, respectively. Abnormal serum AKP was the most frequent (66.9%) and DBILI the least frequent abnormalities (9.1%) detected on the first day of PICU admission. Assessment of LFTs 48 and 96 hours after admission also showed approximately the same frequency rates (table 1) .
On the first day of PICU admission, abnormal levels of all tests except AKP revealed significant relationship with mortality. The results remained statistically significant even after adjusting for PRISM III score. This means that patients with normal test results were 2.39 times more likely to survive in PICU than those with abnormal test results (table 2). After 48 hours, the probability of death was still significantly higher in the groups with abnormal serum ALT, TBILI, DBILI, and INR levels (table 3) and after 96 hours, patients with abnormal TBILI, DBILI, and INR had a higher rate of mortality compared with those with normal test results. Moreover, in univariate analysis, patients with abnormal AST level were still 5.6 times more likely to die compared with those with normal results (OR: 5.6, 95% CI: 1-29.7, P < 0.03) (table 4). In multivariable logistic regression, ALT and INR in the first 24 hours had significant relationship with mortality in final model (table 5) .
Univariate logistic regression revealed that patients with abnormal AST and ALT had higher length of PICU stay (LOS) compared with the patients with normal aforementioned LFTs, at the first day of admission and 48 hours later (p < 0.05). Nevertheless, no significant differences were observed between the patients with normal and abnormal LFTs regarding the length of PICU stay at 48 and 96 hours after admission (p > 0.05, table 6). However, multivariable analysis showed no significant association between these variables and PICU length of stay, except for AST in the first 24 hours.
DISCUSSION
In this study, early liver dysfunction occurred within 24 hours of admission in 66.9% of critically ill children without any previous history of liver problems and was an applicable predictor of PICU mortality. Both conditional logistic regression and logistic regression demonstrated independent effects of early hepatic dysfunction on mortality. It was also shown that increased level of liver enzymes (ALT and AST) could lead to patients' mortality after 24, 48, and 96 hours of admission and increased the PICU length of stay. Based on these results, liver dysfunction could be considered as a main independent prognostic factor for critically ill patients. Results obtained in this research were in close agreement with a study that reported the frequency of 61% increased liver enzymes from medical and surgical adult ICU. 2 However, different studies have reported hepatic dysfunction in 11-60% of cases based on the parameters they used. 2, 3, 6 Hyperbilirubinemia, increased serum transaminases, alkaline phosphatase, lactate dehydrogenase, glutamyl-transferase, decreased serum albumin, and deranged coagulation are pivotal laboratory parameters for diagnosis of hepatic dysfunction. Although these parameters lack specificity and sensitivity, they emerge as a result of bile ducts or hepatocellular injuries and consequently widely used to predict the prognosis of patients in ICUs.
In a prospective multi-center cohort study, serum bilirubin > 2 mg/dL was used as an indicator of liver failure. Kramer and colleagues (2007) reported an independent link between liver dysfunction at the first 48 hours of ICU admission and mortality. 3 TBILI has also been the main focus of such studies and has been used in ICU critical illness scoring systems, including Sequential Organ Failure Assessment and Simplified Acute Physiology Score. 4, 7 Kramer and co-workers (2007) disclosed that early hepatic dysfunction, which is defined as serum bilirubin > 2 mg/dL within 48 hours of admission, could be considered as a major prognostic factor in critically ill patients and increased in-hospital death. 3 In another study conducted in 2010, 11% of the patients suffered from hypoxic hepatitis with prolonged prothrombin time had longer stay in ICU and higher mortality risk. 8 In patients with trauma, hepatic derangement has been an independent predictor of increased mortality and ICU length of stay, irrespective of the absence or 9 It has been demonstrated that elevated ALT was associated with an increased risk of cardiovascular mortality in stable outpatient population. 10 High peak ALT level was also identified as an independent predictor of worse clinical outcome and severe illness in patients with acute respiratory syndrome.
In agreement with our findings, Raurich and colleagues (2011) reported significant differences in serum levels of AST, LDH, INR, and creatinine between survivors and non-survivors, but not in their serum TBILI and ALT levels. 11 Findings of the current study demonstrated that abnormal ALT and AST levels could lead to increased PICU length of stay. This was consistent with a previous study that proposed hepatic dysfunction as an independent predictor of mortality and increased ICU length of stay, irrespective of the absence or presence of additional organs dysfunction. 9 Translating our results into clinical practice, ICU physicians should pay more attention to the systemic ischemic injuries in patients with elevated aminotransferase, TBILI, and DBILI, and deranged INR. These may lead to early recognition of hypo-perfusion and the implementation of specific treatments. In view of a great number of immunological, regulatory, and metabolic functions of liver, early liver dysfunction has a wide array of pathophysiological implications and should be considered as a main independent risk factor in critically patients. Determining the prognostic role of early hepatic dysfunction can prompt research into liver-protecting strategies, as these could play a critical role in controlling the mortality.
The present study had some limitations. We were unable to retrieve the necessary information after the patients were discharged from PICU. Therefore, the number of participating patients declined gradually 96 hours after admission and their data were not considered in statistical analysis. Identifying the exact cause of liver failure in all studied patients was also another limitation of this research.
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